Single Cell Mass Spectrometry Quantification of Anticancer Drugs: Proof of Concept in Cancer Patients
- 12 February 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 4 (1), 96-100
- https://doi.org/10.1021/acsptsci.0c00156
Abstract
In clinical cancer medicine, the current inability to quantify intracellular chemotherapy drug concentrations in individual human cells limits the personalization and overall effectiveness of drug administration. New bioanalytical methods capable of real-time measurement of drug levels in live single cancer cells would allow for more adaptive and personalized administration of chemotherapy drugs, potentially leading to better clinical outcomes with fewer side effects. In this study, we report the development of a new quantitative single cell mass spectrometry (qSCMS) method capable of providing absolute drug amounts and concentrations in single cancer cells. Using this qSCMS system, quantitative analysis of the intracellular drug gemcitabine present in individual bladder cancer cells is reported, including in bladder cancer cells isolated from patients undergoing standard-of-care gemcitabine chemotherapy. The development of single cell pharmacology bioanalytical methods can potentially lead to more effective and safely administered drug medications in patients, especially in the treatment of cancer.Funding Information
- National Cancer Institute (R21CA204706)
- National Institute of General Medical Sciences (R01GM116116)
This publication has 30 references indexed in Scilit:
- Metabolomic Studies of Live Single Cancer Stem Cells Using Mass SpectrometryAnalytical Chemistry, 2018
- Advances in mass spectrometry based single-cell metabolomicsThe Analyst, 2018
- Single-cell analysis tools for drug discovery and developmentNature Reviews Drug Discovery, 2015
- The Single-Probe: A Miniaturized Multifunctional Device for Single Cell Mass Spectrometry AnalysisAnalytical Chemistry, 2014
- Therapeutic drug monitoring in cancer – Are we missing a trick?European Journal of Cancer, 2014
- Quantitative study of cellular heterogeneity in doxorubicin uptake and its pharmacological effect on cancer cellsBiomedical Chromatography, 2014
- Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug ResistanceClinical Pharmacology & Therapeutics, 2012
- Live single‐cell video‐mass spectrometry for cellular and subcellular molecular detection and cell classificationJournal of Mass Spectrometry, 2008
- Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomographyHead & Neck, 1997
- Properties of the K562 cell line, derived from a patient with chronic myeloid leukemiaInternational Journal of Cancer, 1976